↓ Skip to main content

Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant…

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC)
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-p145
Authors

Charles G Drake, David Quinn, Robert Dreicer, Emmanuel Antonarakis, Neal Shore, John Corman, Raoul Concepcion, Christopher Pieczonka, Dwayne Campogan, Li-Qun Fan, Nancy Chang, Nadeem Sheikh, Daniel Petrylak

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 18%
Student > Bachelor 2 12%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 9 53%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 18%
Medicine and Dentistry 3 18%
Agricultural and Biological Sciences 1 6%
Nursing and Health Professions 1 6%
Unknown 9 53%